The Effect of Piperine Pro-Nano Lipospheres on Direct Intestinal Phase II Metabolism: The Raloxifene Paradigm of Enhanced Oral Bioavailability.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Molecular Pharmaceutics

• Publication date

  2018-03-14

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/acs.molpharmaceut.7b01090PMID 29537855
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Improving oral bioavailability of resveratrol by a UDP‐glucuronosyltransferase inhibitory excipient‐based self‐microemulsion

  2018cited by this paper
• The effect of Pro NanoLipospheres (PNL) formulation containing natural absorption enhancers on the oral bioavailability of delta‐9‐tetrahydrocannabinol (THC) and cannabidiol (CBD) in a rat model

  2017cited by this paper
• Sodium Oleate-Based Nanoemulsion Enhances Oral Absorption of Chrysin through Inhibition of UGT-Mediated Metabolism.

  2017cited by this paper
• The biopharmaceutical classification system of excipients.

  2017cited by this paper
• Alamethicin for using in bioavailability studies? - Re-evaluation of its effect.

  2017cited by this paper
• Challenges and Opportunities with Predicting In Vivo Phase II Metabolism via Glucuronidation From In Vitro Data

  2016cited by this paper
• Dietary fats and pharmaceutical lipid excipients increase systemic exposure to orally administered cannabis and cannabis-based medicines.

  2016cited by this paper
• Prediction of hepatic and intestinal glucuronidation using in vitro-in vivo extrapolation.

  2015cited by this paper
• A comprehensive review of UDP-glucuronosyltransferase and esterases for drug development.

  2015cited by this paper
• Self-nano-emulsifying drug delivery systems: an update of the biopharmaceutical aspects

  2015cited by this paper
• Role of herbal bioactives as a potential bioavailability enhancer for Active Pharmaceutical Ingredients.

  2014cited by this paper
• Improved Oral Bioavailability of BCS Class 2 Compounds by Self Nano-Emulsifying Drug Delivery Systems (SNEDDS): The Underlying Mechanisms for Amiodarone and Talinolol

  2013cited by this paper
• Bioavailability enhancers of herbal origin: an overview.

  2013cited by this paper
• Lipospheres and pro-nano lipospheres for delivery of poorly water soluble compounds.

  2012cited by this paper
• In vitro and in situ evaluation of herb-drug interactions during intestinal metabolism and absorption of baicalein.

  2012cited by this paper
• Extensive intestinal glucuronidation of raloxifene in vivo in pigs and impact for oral drug delivery

  2012cited by this paper
• Automation and Miniaturization of the Bioluminescent UGT-Glo Assay for Screening of UDP-Glucuronosyltransferase Inhibition by Various Compounds

  2011cited by this paper
• Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes.

  2011cited by this paper
• Prediction of Human Drug Clearance by Multiple Metabolic Pathways: Integration of Hepatic and Intestinal Microsomal and Cytosolic Data

  2011cited by this paper
• Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities.

  2011cited by this paper
• Phase II drug metabolizing enzymes.

  2010cited by this paper
• Effect of piperine, a major component of black pepper, on the intestinal absorption of fexofenadine and its implication on food-drug interaction.

  2010cited by this paper
• Characterization of Human Hepatic and Extrahepatic UDP-Glucuronosyltransferase Enzymes Involved in the Metabolism of Classic Cannabinoids

  2009cited by this paper
• Enhancing intestinal drug solubilisation using lipid-based delivery systems.

  2008cited by this paper
• Pharmaceutical excipients inhibit cytochrome P450 activity in cell free systems and after systemic administration.

  2008cited by this paper
• The effects of pharmaceutical excipients on drug disposition.

  2007cited by this paper
• Human Cannabinoid Pharmacokinetics

  2007cited by this paper
• In vitro-in vivo correlation for drugs and other compounds eliminated by glucuronidation in humans: pitfalls and promises.

  2006cited by this paper
• Effects of piperine, the pungent component of black pepper, at the human vanilloid receptor (TRPV1)

  2005cited by this paper
• DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS

  2004cited by this paper
• Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs.

  2004cited by this paper
• Piperine enhances the bioavailability of the tea polyphenol (-)-epigallocatechin-3-gallate in mice.

  2004cited by this paper
• Piperine, a Major Constituent of Black Pepper, Inhibits Human P-glycoprotein and CYP3A4

  2002cited by this paper
• Characterization of raloxifene glucuronidation in vitro: contribution of intestinal metabolism to presystemic clearance.

  2002cited by this paper
• Pharmacokinetics of raloxifene and its clinical application.

  1999cited by this paper
• Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers.

  1998cited by this paper
• Kinetics of drug action in disease states. XXXVI: Effect of cyclosporine on the pharmacodynamics and pharmacokinetics of a barbiturate (heptabarbital) in rats.

  1990cited by this paper
• Metabolites of cannabidiol identified in human urine.

  1990cited by this paper

• Lovastatin Loaded Piperine Enabled Nanostructured Lipid Carriers for Improvement of Ex vivo Permeation, Oral Bioavailability, and Antihyperlipidemic Activity

  2025cites this paper
• Nanomaterials‐Based Drug Delivery Systems for Therapeutic Applications in Osteoporosis

  2025cites this paper
• Glucuronidation of orally administered drugs and the value of nanocarriers in strategies for its overcome.

  2024cites this paper
• Piperine: A possible permeation enhancer for oral protein delivery

  2024cites this paper
• Self-nanoemulsifying drug delivery systems (SNEDDS) of anti-cancer drugs: a multifaceted nanoplatform for the enhancement of oral bioavailability

  2023cites this paper
• Piperine Loaded Drug Delivery Systems for Improved Biomedical Applications: Current Status and Future Directions

  2023cites this paper
• Molecular and pharmacological aspects of piperine as a potential molecule for disease prevention and management: evidence from clinical trials

  2022cites this paper
• QbD Approach towards Robust Design Space for Flutamide/PiperineSelf-Emulsifying Drug Delivery System with Reduced Liver Injury

  2022cites this paper
• An imaging approach for determining the mechanism of enhancement of intestinal absorption of an L-theanine supplement

  2021cites this paper
• Characterization of Formononetin Sulfonation in SULT1A3 Overexpressing HKE293 Cells: Involvement of Multidrug Resistance-Associated Protein 4 in Excretion of Sulfate

  2021cites this paper
• Bioadhesive polymer/lipid hybrid nanoparticles as oral delivery system of raloxifene with enhancive intestinal retention and bioavailability

  2021cites this paper
• Recent Developments in Solid Lipid Microparticles for Food Ingredients Delivery

  2021cites this paper
• Spices and herbs as immune enhancers and anti-inflammatory agents: A review

  2021cites this paper
• Formulation of Chitosan-Coated Piperine NLCs: Optimization, In Vitro Characterization, and In Vivo Preclinical Assessment

  2021cites this paper
• Traditional herbal medicine and nanomedicine: Converging disciplines to improve therapeutic efficacy and human health.

  2021cites this paper
• A review on the bioavailability, bio-efficacies and novel delivery systems for piperine.

  2021cites this paper
• The Effect of Medium Chain and Long Chain Triglycerides Incorporated in Self-Nano Emulsifying Drug Delivery Systems on Oral Absorption of Cannabinoids in Rats.

  2020cites this paper
• Controlled delivery of apomorphine through buccal mucosa, towards a noninvasive administration method in Parkinson's disease: a preclinical mechanistic study.

  2020cites this paper
• Enhancing in vivo oral bioavailability of cajaninstilbene acid using UDP-glucuronosyl transferase inhibitory excipient containing self-microemulsion.

  2020cites this paper
• The Effect of Piperine on Oral Absorption of Cannabidiol following Acute vs. Chronic Administration.

  2020cites this paper
• A Non-Lipolysis Nanoemulsion Improved Oral Bioavailability by Reducing the First-Pass Metabolism of Raloxifene, and Related Absorption Mechanisms Being Studied

  2020cites this paper
• Prediction of drug metabolites using neural machine translation

  2020cites this paper
• Self-Generating nano-emulsification techniques for alternatively-routed, bioavailability enhanced delivery, especially for anti-cancers, anti-diabetics, and miscellaneous drugs of natural, and synthetic origins

  2020cites this paper
• Piperine: role in prevention and progression of cancer

  2019cites this paper
• Oral aktive Peptide: Gibt es ein Patentrezept?

  2018cites this paper
• Orally Active Peptides: Is There a Magic Bullet?

  2018cites this paper